Press Release: Bulgarian Cystic Fibrosis Patient Joins International Campaign Standing up for the Rights of Patients to Access Essential Medicines

Bulgarian cystic fibrosis patient joins international campaign standing up for the rights of patients to access essential medicines Rositsa Malinova, a 22-year-old resident of Pazardzhik, Bulgaria, is taking on the…

Continue Reading Press Release: Bulgarian Cystic Fibrosis Patient Joins International Campaign Standing up for the Rights of Patients to Access Essential Medicines
Cystic Fibrosis Patients May Now Be Able to Have Hearing Loss Screenings Done Via Tablets
source: pixabay.com

Cystic Fibrosis Patients May Now Be Able to Have Hearing Loss Screenings Done Via Tablets

by Danielle Bradshaw from In The Cloud Copy A recently performed study has demonstrated that it is possible to use tablets to screen patients that have chronic lung conditions -…

Continue Reading Cystic Fibrosis Patients May Now Be Able to Have Hearing Loss Screenings Done Via Tablets
KALYDECO Now the First FDA-Approved CFTR Modulator for Pediatric Patients with Cystic Fibrosis
1041483 / Pixabay

KALYDECO Now the First FDA-Approved CFTR Modulator for Pediatric Patients with Cystic Fibrosis

  On September 25, biotechnology company Vertex Pharmaceuticals Incorporated ("Vertex") announced FDA-approval of KALYDECO (ivacaftor) for pediatric patients with cystic fibrosis (CF). Specifically, KALYDECO can treat infants between 4-6 months…

Continue Reading KALYDECO Now the First FDA-Approved CFTR Modulator for Pediatric Patients with Cystic Fibrosis